Study Data from C. Frois et al Provide New Insights into Managed Care (Outcomes-Based Contracting Experience: Research Findings from US and European…

Study Data from C. Frois et al Provide New Insights into Managed Care (Outcomes-Based Contracting Experience: Research Findings from US and European Stakeholders)

By a News Reporter-Staff News Editor at Insurance Weekly News -- Researchers detail new data in Managed Care. According to news reporting from Boston, Massachusetts, by VerticalNews journalists, research stated, "Outcomes-based contracts (OBCs), a type of risk-sharing arrangement (RSA), have emerged as a promising avenue for payers to engage with pharmaceutical manufacturers to share risk and improve patient access to medicines via evaluation of real-world outcomes. To assess the level of recent OBC activity and stakeholder perceptions of these arrangements, as well as the outlook for future OBC activity from a payer and manufacturer perspective in the United States and EU-5 (France, Germany, Italy, Spain, and the United Kingdom)."

The news correspondents obtained a quote from the research, "Using a structured questionnaire, interviews were conducted with 27 experts, including 14 U.S. payers, 5 EU-5 national payers, and 8 manufacturer pricing/market access executives (4 U.S., 4 EU-5). We also used the University of Washington's Performance Based Risk-Sharing (PBRS) database and other targeted publicly available information. Publicly disclosed information on OBCs understates the level of OBC activity, since many arrangements are confidential. Overall, U.S. and EU-5 interviewees generally expected that 2 to 3 times more OBCs would be implemented in the next 5 years than in the previous 5 years. Key drivers included the introduction of a national OBC framework in Spain, potentially a similar framework in the United Kingdom, a growing sickness fund activity in Germany, and a U.S. movement towards accountable care. Motivation for OBCs varied markedly across markets and stakeholders, with operational feasibility noted as a significant hurdle in the United States and France. Along with improving health outcomes, cost and financial risk reduction were the primary OBC motivators for payers, while potential access or reimbursement gains were key factors for manufacturers."

According to the news reporters, the research concluded: "Using direct input from U.S. and EU-5 payer and pharmaceutical manufacturer decision makers, this research suggests that high OBC growth is expected in the EU-5 and, to a more moderate extent, in the United States, particularly if clear, simpler OBC frameworks can be developed."

For more information on this research see: Outcomes-Based Contracting Experience: Research Findings from US and European Stakeholders. Journal of Managed Care & Specialty Pharmacy, 2017;23(10):1018-1026. Journal of Managed Care & Specialty Pharmacy can be contacted at: Acad Managed Care Pharmacy, 100 N Pitt St, 400, Alexandria, VA 22314-3134, USA.

Our news journalists report that additional information may be obtained by contacting C. Frois, Anal Grp, Boston, MA 02199, United States. Additional authors for this research include J.J. Ko, R. Sasane, T. Nazareth, S. Carpenter, S. Demean, A. Vegesna, E. Wu and R.P. Navarro.

Keywords for this news article include: Boston, Massachusetts, United States, North and Central America, Managed Care.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC